Rajendra, Akhil
Gupta, Vikas https://orcid.org/0000-0002-1419-8607
Funding for this research was provided by:
VG is supported by Barbara Baker Chair in Leukemia and Related Disorders, and The Elizabeth and Tony Comper Foundation.
Article History
Accepted: 5 August 2024
First Online: 6 September 2024
Declarations
:
: Not applicable.
: Not applicable.
: V.G. reports consultancy: AbbVie, Bristol Myers Squibb–Celgene, Novartis, Pfizer, Daiichi Sankyo, GSK, Incyte; data safety or advisory board participation: AbbVie, Bristol Myers Squibb–Celgene, GSK, Incyte; honoraria: Bristol Myers Squibb–Celgene, Novartis; research support: Novartis, AbbVie. A.R. has no COI to declare.